Multiple reports highlight the performance of the International Flavors & Fragrances Inc (IFF). The company's Q3 2024 performance exceeded revenue forecasts but fell short on the EPS. The sales were boosted by the fragrance and health products segment, leading to raised forecasts. IFF's stock performance has been mixed, underperforming on some days compared to competitors. However, it saw an upgrade from Vertical Research and Bank of America. The selling off of shares by several investment companies indicates cautious sentiment. The company was also recently impacted by a 14.15% drop in value over four weeks but analysts are predicting a comeback. Amid these developments, IFF sold its pharma unit to France's Roquette in a $2.85 billion deal. However, the Street analysts remain bullish on IFF due to its wide moat. Despite its recent challenges, IFF still ranks as a top pick in Carl Icahn’s stock portfolio and is set to open a flavor & fragrance innovation center.
International Flavors Fragrances IFF News Analytics from Fri, 01 Dec 2023 08:00:00 GMT to Fri, 08 Nov 2024 22:06:00 GMT -
